Portrait of Jennifer Geremia

Jennifer Geremia,

MSPAS, PA-C

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital & Teaching Hospital of Harvard Medical School
Portrait of Jennifer Geremia

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital & Teaching Hospital of Harvard Medical School

Jennifer Geremia, MSPAS, PA-C, is a practicing physician associate (PA) in outpatient gastroenterology (GI) and advanced endoscopy at Brigham and Women’s Hospital in Boston at Teaching Hospital of Harvard Medical School. With GI experience for 14 years, including providing community and tertiary care across the spectrum of GI disease states, Jennifer is committed to patient care. She obtained a master’s degree in physician assistant studies from Massachusetts College of Pharmacy and Health Sciences. She is part of the clinical faculty at Massachusetts College of Pharmacy and Health Sciences PA Program, adjunct professor with GI experience at the University of New England PA program, and the Massachusetts General Hospital School of Health Professions PA Program. Also, she is a conference faculty presenter for the Gastroenterology and Hepatology Advanced Practice Providers National Organization and an advanced practice provider contributor to the American Society for Gastrointestinal Endoscopy.

Jennifer's Shared Resources

Update on Hepatitis C Care Paradigm for Healthcare Practitioners

The care paradigm for hepatitis C has recently shifted. This activity helps ensure healthcare practitioners, including hepatologists, gastroenterologists, primary care...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Risk Factors for Liver-Related Events Post-SVR in Patients With Hepatitis C

An observational, retrospective study examined the risk factors for liver-related events (LREs) after achieving sustained virological response (SVR) with direct-acting...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Advanced Liver Disease and Hepatocellular Carcinoma Linked to Higher Mortality With Hepatitis C

Failure to achieve sustained virological response (SVR) and the presence of advanced liver disease are linked to higher mortality in...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Impact of Biomedical and Clinical Efforts on Antiviral Treatments

In the 1970s, many cases of transfusion-associated hepatitis, termed non-A, non-B hepatitis (NANBH), were reported without a known cause until...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Significant Fibrosis Regression

Hepatitis C virus (HCV) infection can lead to serious liver-related events (LRE) such as hepatocellular carcinoma (HCC), liver decompensation, and...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Algorithms Predict Hepatocellular Carcinoma Development

Hepatocellular carcinoma (HCC) is a significant concern for patients with advanced chronic liver disease (ACLD) caused by chronic hepatitis C,...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Provided by an unrestricted grant from

Provided by an unrestricted grant from

Share